Federal regulators plan to restrict high-concentration 7-OH products as early as Friday, targeting synthetic kratom derivatives while leaving traditional botanical leaf powders untouched following industry pushback and agency reviews.
Federal regulators plan to restrict high-concentration 7-OH products as early as Friday, targeting synthetic kratom derivatives while leaving traditional botanical leaf powders untouched following industry pushback and agency reviews.
Federal Crackdown Targets High-Concentration 7-OH Products
The U.S. Drug Enforcement Administration and the Department of Health and Human Services plan to restrict a narrower range of 7-hydroxymitragynine and mitragynine pseudoindoxyl products that contain elevated concentrations of the substances, according to [npr.org].
In New Hampshire, state Senator Bill Gannon proposed a bill ahead of the January legislative session to classify kratom as a Schedule 1 drug, [nhpr.org] reported. Several municipal boards in communities such as Manchester and Seabrook are weighing local bans or tighter regulations on synthetic variants.
Poison Control Calls and Emergency Room Visits Surge
Data from the University of Virginia shows reports of calls related to kratom to 53 U.S. poison control centers increased about 1,200% between 2015 and 2025, rising from 258 calls to 3,434 calls, [WSET] reported. Emergency room visits associated with the substance climbed from 43 to 538 over the same decade.
Chris Holstege, a physician and professor of emergency medicine and pediatrics at the University of Virginia’s School of Medicine, said he and other authors of a recent poisoning data report were “a bit stunned” by the findings. The poison data identified 233 deaths associated with kratom between 2015 and 2025, with 79% of those fatalities involving multiple substances alongside kratom, according to [npr.org].
Consumers Describe Severe Addiction and Difficult Withdrawals
Users frequently purchase concentrated 7-OH tablets, gummies, and tonics at local gas stations, vape shops, and liquor stores, where products are often displayed near checkout counters. David Epstein, a senior investigator at the National Institute on Drug Abuse Intramural Research Program, said ongoing research suggests the risk of dependence is higher with concentrated 7-OH than with whole leaf kratom.
“Once I found these little tiny tablets — that I had to take one and it felt like I had taken an Oxycontin — you know, that was it,” Brian told [npr.org].
“It was game over.” Brian, who spent approximately $150 each day on 1,200 milligrams of 7-OH at the height of his use, quit cold turkey in April 2026. Angela Wilson told [npr.org] that taking 32 to 40 milligrams of 7-OH daily helps her manage endometriosis pain and depressive symptoms without the shaky side effects she experienced from raw kratom powders.
Frequently Asked Questions About Kratom and 7-OH Restrictions
What specific products are affected by the federal action?
The upcoming federal restrictions target products containing high concentrations of 7-hydroxymitragynine and related semi-synthetic compounds like mitragynine pseudoindoxyl, while natural botanical leaf powders remain outside the current enforcement scope, according to [npr.org].
How do poison control call volumes compare over the decade?
Poison control center calls regarding kratom increased by approximately 1,200% between 2015, when 258 calls were logged, and 2025, when calls reached 3,434, [WSET] reported.
Keep reading